Tissue-specific proteasomes in generation of MHC class I peptides and CD8+ T cells
- PMID: 35689940
- PMCID: PMC9339533
- DOI: 10.1016/j.coi.2022.102217
Tissue-specific proteasomes in generation of MHC class I peptides and CD8+ T cells
Abstract
Thymoproteasomes and immunoproteasomes are two types of tissue-specific proteasomes, which contribute to the production of major histocompatibility complex (MHC) class I (MHC-I)-associated peptides that are important for the development and function of CD8+ cytotoxic T cells. Thymoproteasomes are specifically expressed by cortical thymic epithelial cells and are important for MHC-I-dependent positive selection of developing thymocytes, whereas immunoproteasomes are abundant in many other cells, including hematopoietic cells and medullary thymic epithelial cells. Here we summarize the role of these two tissue-specific proteasomes, focusing on their functions in the development of CD8+ T cells in the thymus.
Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The Role of Proteasomes in the Thymus.Front Immunol. 2021 Mar 19;12:646209. doi: 10.3389/fimmu.2021.646209. eCollection 2021. Front Immunol. 2021. PMID: 33815406 Free PMC article. Review.
-
The role of the proteasome in the generation of MHC class I ligands and immune responses.Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9. Cell Mol Life Sci. 2011. PMID: 21387144 Free PMC article. Review.
-
Peptides for T cell selection in the thymus.Peptides. 2021 Dec;146:170671. doi: 10.1016/j.peptides.2021.170671. Epub 2021 Oct 5. Peptides. 2021. PMID: 34624431 Free PMC article. Review.
-
Regulation of CD8+ T cell development by thymus-specific proteasomes.Science. 2007 Jun 1;316(5829):1349-53. doi: 10.1126/science.1141915. Science. 2007. PMID: 17540904
-
Proteasomes in immune cells: more than peptide producers?Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11. Nat Rev Immunol. 2010. PMID: 20010787 Review.
Cited by
-
Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects.Vaccines (Basel). 2022 Aug 7;10(8):1272. doi: 10.3390/vaccines10081272. Vaccines (Basel). 2022. PMID: 36016159 Free PMC article. Review.
-
Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.Diagn Pathol. 2024 Feb 10;19(1):29. doi: 10.1186/s13000-024-01454-9. Diagn Pathol. 2024. PMID: 38341587 Free PMC article.
-
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanoma.Oncoimmunology. 2024 Jun 27;13(1):2370928. doi: 10.1080/2162402X.2024.2370928. eCollection 2024. Oncoimmunology. 2024. PMID: 38948930 Free PMC article.
-
Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma.BMC Cancer. 2023 Oct 18;23(1):1001. doi: 10.1186/s12885-023-11288-1. BMC Cancer. 2023. PMID: 37853322 Free PMC article.
-
From oncogenesis to prognosis: the roles of the immunoproteasome in cancer.Front Immunol. 2025 Jul 8;16:1603816. doi: 10.3389/fimmu.2025.1603816. eCollection 2025. Front Immunol. 2025. PMID: 40698074 Free PMC article. Review.
References
-
- Murata S, Takahama Y, Kasahara M, Tanaka K: The immunoproteasome and thymoproteasome: functions, evolution and human disease. Nat Immunol 2018, 19:923–931. - PubMed
-
- Murata S, Sasaki K, Kishimoto T, Niwa S-I, Hayashi H, Takahama Y, Tanaka K: Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 2007, 316:1349–1353. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials